A new artificial intelligence tool is being developed to help investors identify scientific research with the potential to become valuable patents. While the approach could accelerate investment decisions, researchers caution that the tool is not without limitations.
Published online on August 20, 2026, in *Nature*, the AI aims to streamline the process of evaluating research for its commercial viability. The tool’s core function is to analyze scientific literature and predict which findings are most likely to lead to patentable inventions. This capability is intended to speed up investment decisions by providing a preliminary assessment of a study’s potential.
However, researchers involved in the development emphasize that the AI is not foolproof. The article notes that the tool “has flaws,” suggesting that human oversight and expert judgment remain crucial components of the investment process. The *Nature* article’s DOI is 10.1038/d41586-026-02549-7.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy